Gerald Jäeger, Peter Neumeister, Ruth Brezinschek, Gerald Höfler, Franz Quehenberger, Werner Linkesch and Heinz Sill Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study European Journal of Haematology 69
Article first published online: 19 SEP 2002 | DOI: 10.1034/j.1600-0609.2002.01692.x
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.